This is a Validated Antibody Database (VAD) review about mouse Pdcd1lg2, based on 51 published articles (read how Labome selects the articles), using Pdcd1lg2 antibody in all methods. It is aimed to help Labome visitors find the most suited Pdcd1lg2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Pdcd1lg2 synonym: B7-DC; Btdc; F730015O22Rik; PD-L2

BioLegend
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig s2e
BioLegend Pdcd1lg2 antibody (BioLegend, 107205) was used in flow cytometry on mouse samples (fig s2e). Sci Immunol (2021) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Pdcd1lg2 antibody (BioLegend, Ty25) was used in flow cytometry on mouse samples at 1:200. J Immunother Cancer (2021) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig 4h
BioLegend Pdcd1lg2 antibody (Biolegend, TY25) was used in flow cytometry on mouse samples (fig 4h). PLoS Pathog (2021) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Pdcd1lg2 antibody (BioLegend, TY25) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2021) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse
BioLegend Pdcd1lg2 antibody (Biolegend, 107202) was used in flow cytometry on mouse samples . Cancer Cell (2021) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig s9c
BioLegend Pdcd1lg2 antibody (Biolegend, 107214) was used in flow cytometry on mouse samples (fig s9c). Mol Cancer (2021) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend Pdcd1lg2 antibody (Biolegend, 107205) was used in flow cytometry on mouse samples (fig s2b). J Clin Invest (2021) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...
BioLegend Pdcd1lg2 antibody (Biolegend, 107210) was used in flow cytometry on mouse samples . Cell (2021) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; 1:200; loading ...; fig 4
BioLegend Pdcd1lg2 antibody (BioLegend, 107203) was used in flow cytometry on mouse samples at 1:200 (fig 4). Nat Commun (2020) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig 6s2
BioLegend Pdcd1lg2 antibody (Biolegend, TY25) was used in flow cytometry on mouse samples (fig 6s2). elife (2020) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; 1:300; loading ...; fig 1a
BioLegend Pdcd1lg2 antibody (Biolegend, TY25) was used in flow cytometry on mouse samples at 1:300 (fig 1a). elife (2019) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; 1:200; loading ...; fig ex4a
BioLegend Pdcd1lg2 antibody (BioLegend, 107210) was used in flow cytometry on mouse samples at 1:200 (fig ex4a). Nature (2019) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend Pdcd1lg2 antibody (Biolegend, 107205) was used in flow cytometry on mouse samples (fig 2e). Sci Rep (2019) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig s1g
BioLegend Pdcd1lg2 antibody (Biolegend, 107205) was used in flow cytometry on mouse samples (fig s1g). Cell (2019) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend Pdcd1lg2 antibody (Biolegend, T425) was used in flow cytometry on mouse samples (fig 6b). J Neurosci (2018) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Pdcd1lg2 antibody (BioLegend, TY25) was used in flow cytometry on mouse samples (fig 1d). Immunology (2017) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig 7e
In order to examine skin dendritic cells from mice exposed to two different Th2 stimuli, BioLegend Pdcd1lg2 antibody (BioLegend, Ty25) was used in flow cytometry on mouse samples (fig 7e). J Exp Med (2017) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig s2a
In order to investigate the role of mTOR in plasma cell differentiation and antibody production in RAPTOR deficient cells., BioLegend Pdcd1lg2 antibody (BioLegend, TY25) was used in flow cytometry on mouse samples (fig s2a). J Clin Invest (2016) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig 2
In order to test if a diet high in fats affects the development of respiratory tolerance, BioLegend Pdcd1lg2 antibody (Biolegend, Ty25) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (TY25)
BioLegend Pdcd1lg2 antibody (BioLegend, 107202) was used . Nat Commun (2016) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig 1
BioLegend Pdcd1lg2 antibody (Biolegend, TY25) was used in flow cytometry on mouse samples (fig 1). Nat Commun (2015) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig 3
In order to assess whether programmed cell death 1 regulates psoriasiform dermatitis in mice, BioLegend Pdcd1lg2 antibody (BioLegend, TY25) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig 5c
In order to show that CD326(lo)CD103(lo)CD11b(lo) dermal dendritic cells respond to thymic stromal lymphopoietin, BioLegend Pdcd1lg2 antibody (BioLegend, TY25) was used in flow cytometry on mouse samples (fig 5c). J Immunol (2014) ncbi
Invitrogen
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in flow cytometry on mouse samples (fig 1b). Front Immunol (2019) ncbi
rat monoclonal (122)
  • flow cytometry; mouse; loading ...; fig 7c
Invitrogen Pdcd1lg2 antibody (eBioscience, 122) was used in flow cytometry on mouse samples (fig 7c). J Clin Invest (2019) ncbi
rat monoclonal (122)
  • flow cytometry; mouse; loading ...; fig 6c
Invitrogen Pdcd1lg2 antibody (eBioscience, 11-9972-82) was used in flow cytometry on mouse samples (fig 6c). Nat Commun (2018) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig 3a
In order to elucidate how schistosome-induced B cells protect against allergic airway inflammation, Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in flow cytometry on mouse samples (fig 3a). Int J Parasitol (2017) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 2a
In order to assess the critical role of programmed death protein 1/programmed death-ligand 1 in the polarization of microglia during intracerebral hemorrhage-induced secondary brain injury, Invitrogen Pdcd1lg2 antibody (Thermo Fisher, PA5-20344) was used in western blot on rat samples (fig 2a). J Neuroinflammation (2017) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig 1b
In order to elucidate the role of interferon regulatory factor 4 in dendritic cells, Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in flow cytometry on mouse samples (fig 1b). J Cell Biol (2017) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig s3d
In order to explore the role of exhausted CD8 positive CXCR5 positive T cells in mice chronically infected with lymphocytic choriomeningitis virus, Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in flow cytometry on mouse samples (fig s3d). Nature (2016) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig 4
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen Pdcd1lg2 antibody (eBioscience, Ty25) was used in flow cytometry on mouse samples (fig 4). J Clin Invest (2016) ncbi
rat monoclonal (122)
  • flow cytometry; mouse; loading ...; fig 3e
In order to compare the capacity of induced T regulatory and T helper 17 cells to develop in a T cell model of colitis, Invitrogen Pdcd1lg2 antibody (eBioscience, 122) was used in flow cytometry on mouse samples (fig 3e). J Immunol (2016) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, Invitrogen Pdcd1lg2 antibody (eBiosciences, TY25) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig 3
Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse
Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in flow cytometry on mouse samples . Proc Natl Acad Sci U S A (2014) ncbi
rat monoclonal (122)
  • flow cytometry; mouse; fig s4
In order to test the efficacy of combining different monoclonal antibodies to treat cancer, Invitrogen Pdcd1lg2 antibody (ebioscience, 14-9972-81) was used in flow cytometry on mouse samples (fig s4). Clin Cancer Res (2015) ncbi
rat monoclonal (122)
  • flow cytometry; human
Invitrogen Pdcd1lg2 antibody (eBioscience, 122) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig 3
In order to examine the contribution of PD-L1 or PD-L2 to limiting stroke severity, Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in flow cytometry on mouse samples (fig 3). J Neuroinflammation (2013) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig s2
Invitrogen Pdcd1lg2 antibody (Ebioscience, Ty25) was used in flow cytometry on mouse samples (fig s2). PLoS Pathog (2013) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse
In order to determine the contribution of the host's circulating progenitor cells after implantation of mesenchymal stem cells/bioscaffold combinations in repairing bone defects, Invitrogen Pdcd1lg2 antibody (eBioscience, Ty25) was used in flow cytometry on mouse samples . Tissue Eng Part A (2009) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse
Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in flow cytometry on mouse samples . Cell Res (2008) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig 1
In order to characterize and compare T helper 1 and 17 cells, Invitrogen Pdcd1lg2 antibody (eBiosciences, TY25) was used in flow cytometry on mouse samples (fig 1). J Leukoc Biol (2007) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse
In order to investigate the roles of PD-L1 and PD-L2 expressed by dendritic cells in naive CD4+ T cell activation, Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in flow cytometry on mouse samples . Eur J Immunol (2006) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig 1
In order to determine the in vivo functions of B7-DC using knockout mice, Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in flow cytometry on mouse samples (fig 1). J Exp Med (2005) ncbi
rat monoclonal (TY25)
  • immunohistochemistry - frozen section; mouse
  • flow cytometry; mouse
Invitrogen Pdcd1lg2 antibody (eBioscience, TY25) was used in immunohistochemistry - frozen section on mouse samples and in flow cytometry on mouse samples . Nephrol Dial Transplant (2004) ncbi
rat monoclonal (TY25)
  • blocking or activating experiments; mouse
  • flow cytometry; mouse
In order to elucidate how Schistosoma mansoni suppresses T cell activation, Invitrogen Pdcd1lg2 antibody (eBiosciences, TY25) was used in blocking or activating experiments on mouse samples and in flow cytometry on mouse samples . J Immunol (2004) ncbi
Bio X Cell
rat monoclonal (TY25)
  • blocking or activating experiments; mouse; fig 6k
Bio X Cell Pdcd1lg2 antibody (BioXcell, TY25) was used in blocking or activating experiments on mouse samples (fig 6k). elife (2020) ncbi
rat monoclonal (TY25)
  • blocking or activating experiments; mouse; fig 1
Bio X Cell Pdcd1lg2 antibody (BioXCell, TY25) was used in blocking or activating experiments on mouse samples (fig 1). J Immunol (2015) ncbi
BD Biosciences
rat monoclonal (TY25)
  • flow cytometry; mouse; 1:300; loading ...; fig 1a
BD Biosciences Pdcd1lg2 antibody (BD, TY25) was used in flow cytometry on mouse samples at 1:300 (fig 1a). elife (2019) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; 2:100; loading ...; fig 1d
BD Biosciences Pdcd1lg2 antibody (BD Biosciences, TY-25) was used in flow cytometry on mouse samples at 2:100 (fig 1d). Biosci Rep (2019) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; loading ...; fig 4a
BD Biosciences Pdcd1lg2 antibody (BD, TY25) was used in flow cytometry on mouse samples (fig 4a). Cancer Immunol Immunother (2019) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; fig 5c
In order to propose that type 2 immunity is induced by a unique mechanism in the genital tract, BD Biosciences Pdcd1lg2 antibody (BD Biosciences, TY25) was used in flow cytometry on mouse samples (fig 5c). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (TY25)
  • flow cytometry; mouse; 1:200; fig 3h
BD Biosciences Pdcd1lg2 antibody (BD, 560086) was used in flow cytometry on mouse samples at 1:200 (fig 3h). Nat Commun (2016) ncbi
Articles Reviewed
  1. Tatsumi N, Codrington A, El Fenej J, Phondge V, Kumamoto Y. Effective CD4 T cell priming requires repertoire scanning by CD301b+ migratory cDC2 cells upon lymph node entry. Sci Immunol. 2021;6:eabg0336 pubmed publisher
  2. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  3. Forman R, Logunova L, Smith H, Wemyss K, Mair I, Boon L, et al. Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages. PLoS Pathog. 2021;17:e1009768 pubmed publisher
  4. Van De Velde L, Allen E, Crawford J, Wilson T, Guy C, Russier M, et al. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells. Cancer Res. 2021;81:5047-5059 pubmed publisher
  5. Hutton C, Heider F, Blanco Gómez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;: pubmed publisher
  6. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  7. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed publisher
  8. Gangoso E, Southgate B, Bradley L, Rus S, Gálvez Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454-2470.e26 pubmed publisher
  9. Aslan K, Turco V, Blobner J, Sonner J, Liuzzi A, Núñez N, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nat Commun. 2020;11:931 pubmed publisher
  10. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  11. Koike T, Harada K, Horiuchi S, Kitamura D. The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets. elife. 2019;8: pubmed publisher
  12. Oh J, Iijima N, Song E, Lu P, Klein J, Jiang R, et al. Migrant memory B cells secrete luminal antibody in the vagina. Nature. 2019;: pubmed publisher
  13. Mizuno R, Sugiura D, Shimizu K, Maruhashi T, Watada M, Okazaki I, et al. PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation. Front Immunol. 2019;10:630 pubmed publisher
  14. Knox T, Sahakian E, Banik D, Hadley M, Palmer E, Noonepalle S, et al. Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells. Sci Rep. 2019;9:6136 pubmed publisher
  15. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  16. Visekruna A, Hartmann S, Sillke Y, Glauben R, Fischer F, Raifer H, et al. Intestinal development and homeostasis require activation and apoptosis of diet-reactive T cells. J Clin Invest. 2019;129:1972-1983 pubmed publisher
  17. Vega Angeles V, Terrazas L, Ledesma Soto Y, Jimenez L, Landa A. Taenia solium glutathione transferase fraction activates macrophages and favors the development of Th1-type response. Biosci Rep. 2019;39: pubmed publisher
  18. Tordesillas L, Lozano Ojalvo D, Dunkin D, Mondoulet L, Agudo J, Merad M, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun. 2018;9:5238 pubmed publisher
  19. Umezu D, Okada N, Sakoda Y, Adachi K, Ojima T, Yamaue H, et al. Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment. Cancer Immunol Immunother. 2019;68:201-211 pubmed publisher
  20. Quenum Zangbede F, Chauhan A, Sharma J, Mishra B. Galectin-3 in M2 Macrophages Plays a Protective Role in Resolution of Neuropathology in Brain Parasitic Infection by Regulating Neutrophil Turnover. J Neurosci. 2018;38:6737-6750 pubmed publisher
  21. Lynch A, Hawk W, Nylen E, Ober S, Autin P, Barber A. Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma. Immunology. 2017;152:472-483 pubmed publisher
  22. van der Vlugt L, Obieglo K, Ozir Fazalalikhan A, Sparwasser T, Haeberlein S, Smits H. Schistosome-induced pulmonary B cells inhibit allergic airway inflammation and display a reduced Th2-driving function. Int J Parasitol. 2017;47:545-554 pubmed publisher
  23. Wu J, Sun L, Li H, Shen H, Zhai W, Yu Z, et al. Roles of programmed death protein 1/programmed death-ligand 1 in secondary brain injury after intracerebral hemorrhage in rats: selective modulation of microglia polarization to anti-inflammatory phenotype. J Neuroinflammation. 2017;14:36 pubmed publisher
  24. Oh J, Oh D, Jung H, Lee H. A mechanism for the induction of type 2 immune responses by a protease allergen in the genital tract. Proc Natl Acad Sci U S A. 2017;114:E1188-E1195 pubmed publisher
  25. Vander Lugt B, Riddell J, Khan A, Hackney J, Lesch J, DeVoss J, et al. Transcriptional determinants of tolerogenic and immunogenic states during dendritic cell maturation. J Cell Biol. 2017;216:779-792 pubmed publisher
  26. Connor L, Tang S, Cognard E, Ochiai S, Hilligan K, Old S, et al. Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles. J Exp Med. 2017;214:125-142 pubmed publisher
  27. Jones D, Gaudette B, Wilmore J, Chernova I, Bortnick A, Weiss B, et al. mTOR has distinct functions in generating versus sustaining humoral immunity. J Clin Invest. 2016;126:4250-4261 pubmed publisher
  28. Bemark M, Hazanov H, Strömberg A, Komban R, Holmqvist J, Köster S, et al. Limited clonal relatedness between gut IgA plasma cells and memory B cells after oral immunization. Nat Commun. 2016;7:12698 pubmed publisher
  29. He R, Hou S, Liu C, Zhang A, Bai Q, Han M, et al. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection. Nature. 2016;537:412-428 pubmed publisher
  30. Pizzolla A, Oh D, Luong S, Prickett S, Henstridge D, Febbraio M, et al. High Fat Diet Inhibits Dendritic Cell and T Cell Response to Allergens but Does Not Impair Inhalational Respiratory Tolerance. PLoS ONE. 2016;11:e0160407 pubmed publisher
  31. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  32. Yang Y, Andersson P, Hosaka K, Zhang Y, Cao R, Iwamoto H, et al. The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages. Nat Commun. 2016;7:11385 pubmed publisher
  33. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed publisher
  34. Kamimura D, Katsunuma K, Arima Y, Atsumi T, Jiang J, Bando H, et al. KDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR. Nat Commun. 2015;6:7474 pubmed publisher
  35. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  36. Imai Y, Ayithan N, Wu X, Yuan Y, Wang L, Hwang S. Cutting Edge: PD-1 Regulates Imiquimod-Induced Psoriasiform Dermatitis through Inhibition of IL-17A Expression by Innate γδ-Low T Cells. J Immunol. 2015;195:421-5 pubmed publisher
  37. Hartung E, Becker M, Bachem A, Reeg N, Jäkel A, Hutloff A, et al. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross-presenting dendritic cells in vivo via murine or human XCR1. J Immunol. 2015;194:1069-79 pubmed publisher
  38. Jaworska K, Ratajczak J, Huang L, Whalen K, Yang M, Stevens B, et al. Both PD-1 ligands protect the kidney from ischemia reperfusion injury. J Immunol. 2015;194:325-33 pubmed publisher
  39. Schwartz C, Turqueti Neves A, Hartmann S, Yu P, Nimmerjahn F, Voehringer D. Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion. Proc Natl Acad Sci U S A. 2014;111:E5169-77 pubmed publisher
  40. Dai M, Yip Y, Hellstrom I, Hellstrom K. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. Clin Cancer Res. 2015;21:1127-38 pubmed publisher
  41. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  42. Ochiai S, Roediger B, Abtin A, Shklovskaya E, Fazekas de St Groth B, Yamane H, et al. CD326(lo)CD103(lo)CD11b(lo) dermal dendritic cells are activated by thymic stromal lymphopoietin during contact sensitization in mice. J Immunol. 2014;193:2504-11 pubmed publisher
  43. Bodhankar S, Chen Y, Vandenbark A, Murphy S, Offner H. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1. J Neuroinflammation. 2013;10:111 pubmed publisher
  44. Van Der Werf N, Redpath S, Azuma M, Yagita H, Taylor M. Th2 cell-intrinsic hypo-responsiveness determines susceptibility to helminth infection. PLoS Pathog. 2013;9:e1003215 pubmed publisher
  45. Tasso R, Augello A, Boccardo S, Salvi S, Carida M, Postiglione F, et al. Recruitment of a host's osteoprogenitor cells using exogenous mesenchymal stem cells seeded on porous ceramic. Tissue Eng Part A. 2009;15:2203-12 pubmed publisher
  46. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, et al. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res. 2008;18:846-57 pubmed publisher
  47. Nakae S, Iwakura Y, Suto H, Galli S. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81:1258-68 pubmed
  48. Kuipers H, Muskens F, Willart M, Hijdra D, van Assema F, Coyle A, et al. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur J Immunol. 2006;36:2472-82 pubmed
  49. Shin T, Yoshimura K, Shin T, Crafton E, Tsuchiya H, Housseau F, et al. In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J Exp Med. 2005;201:1531-41 pubmed
  50. Schoop R, Wahl P, Le Hir M, Heemann U, Wang M, Wuthrich R. Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol Dial Transplant. 2004;19:2713-20 pubmed
  51. Smith P, Walsh C, Mangan N, Fallon R, Sayers J, McKenzie A, et al. Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J Immunol. 2004;173:1240-8 pubmed